Find the Perfect Plan for Your Investment Journey
I
Latest price
52 Week Range
€9.40 - €15.14
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | €297.11M |
EV | €296.65M |
Shares Outstanding | 28.98M |
Beta | 0.94 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | €17.50 |
P/E 2025E | 14.37x |
P/Revenue 2025E | 0.50x |
Revenue | 16.80% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | 6.70% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 34.50% |
Net Profit Margin 2025E | 3.68% |
ROE 2025E | 14.30% |
ROCE 2024 | - |
DPS 2025E | €0.28 |
Payout Ratio 2025E | 40.00% |
Div. Yield 2025E | 2.80% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
I
Ion Beam Applications SA
IBAB
Sector
Healthcare
Industry
Medical - Devices
CEO
Legrain, Olivier
Employees
1,943
Website
www.iba-worldwide.comIPO Date
2000-01-04
Headquarters
3, Chemin du Cyclotron, Louvain-la-Neuve, Walloon Brabant, 1348, Belgium
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved